Indian pharma company Dr. Reddy’s Laboratories said that it has launched Regadenoson Injection 0.4 mg/5 mL in the US market. Approved by the US Food and Drug Administration (FDA), Regadenoson Injection is a generic therapeutic equivalent of Lexiscan (Regadenoson) injection of Astellas US. It is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI). […]
Glenmark Pharmaceuticals said that it has secured tentative approval from the US Food & Drug Administration (FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe. The drug is the generic version of Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US. Lexiscan Injection, 0.4 mg/5 mL (0.08 mg/mL) had annual sales […]
